Global Methionine Aminopeptidase 2 (MetAP2) Market
Market Status, Strategic Assessment & Forecast (2026–2036)
Market Overview
Methionine Aminopeptidase 2 (MetAP2) is a critical intracellular enzyme involved in protein maturation, angiogenesis, and cellular proliferation. Pharmacological inhibition of MetAP2 has emerged as a promising therapeutic strategy across oncology, metabolic disorders, inflammatory diseases, and rare vascular conditions. Renewed interest in MetAP2 inhibitors—supported by improved safety profiles and next-generation molecular designs—is driving sustained research and development momentum.
The global Methionine Aminopeptidase 2 market was valued at USD XX million in 2020 and is projected to reach USD XX million by 2036, expanding at a CAGR of XX% during 2026–2036. Market growth is underpinned by expanding clinical pipelines, rising investment in targeted therapies, and increasing prevalence of cancer and metabolic diseases.
Segments Analysis
By Product Type
-
APL-1301
-
M-8891
-
RSF-101
-
SDX-7195
-
Others
By Drug Class (Expanded Segmentation)
-
Small-Molecule MetAP2 Inhibitors
-
Covalent MetAP2 Inhibitors
-
Non-covalent Enzyme Modulators
-
Combination Therapies (MetAP2 + Anti-angiogenic Agents)
By Indication (New Segmentation)
-
Oncology (solid tumors, hematologic malignancies)
-
Metabolic Disorders (obesity, diabetes-related complications)
-
Inflammatory & Autoimmune Diseases
-
Rare Vascular & Proliferative Disorders
By Route of Administration (Added)
-
Oral
-
Injectable
-
Parenteral
By Application
-
Hospital
-
Clinic
-
Others
Key Market Players
Core Manufacturers
-
Asieris Pharmaceuticals
-
Chong Kun Dang Pharmaceutical
-
Merck KGaA
-
SynDevRx
-
Takeda Pharmaceutical
-
Zafgen
Additional & Emerging Players (Expanded)
-
Pfizer Inc
-
Novartis AG
-
BeiGene Ltd
-
Bristol-Myers Squibb
-
Jiangsu Hengrui Medicine
Regional Analysis
North America
-
Dominant region due to advanced oncology research infrastructure
-
High concentration of clinical trials and biotech funding
-
Strong regulatory support for targeted and orphan therapies
Europe
-
Robust translational research ecosystem
-
Increasing academic–industry collaborations
-
Strong presence of multinational pharmaceutical companies
Asia-Pacific
-
Fastest-growing region driven by China and Japan
-
Rising cancer burden and increasing R&D outsourcing
-
Expanding domestic biotech innovation
Central & South America
-
Gradual market expansion
-
Improving access to oncology therapies
-
Limited but growing clinical research activity
Middle East & Africa
-
Emerging interest in advanced therapeutics
-
Market growth constrained by access and affordability challenges
Porter’s Five Forces Analysis
| Force | Impact |
|---|---|
| Threat of New Entrants | Medium |
| Bargaining Power of Suppliers | Low |
| Bargaining Power of Buyers | Medium |
| Threat of Substitutes | Low |
| Competitive Rivalry | Medium |
SWOT Analysis
Strengths
-
Highly specific molecular target
-
Broad therapeutic potential across multiple indications
-
Increasing validation through clinical pipelines
Weaknesses
-
Historical safety concerns for earlier inhibitors
-
Long clinical development timelines
-
High R&D and regulatory costs
Opportunities
-
Development of safer, next-generation MetAP2 inhibitors
-
Expansion into metabolic and inflammatory indications
-
Combination therapy strategies with immuno-oncology agents
Threats
-
Clinical trial attrition risk
-
Competition from alternative angiogenesis pathways
-
Regulatory scrutiny on long-term safety
Trend Analysis
-
Shift from first-generation to selective, reversible MetAP2 inhibitors
-
Increased focus on oncology and metabolic disease convergence
-
Rising use of biomarker-driven patient stratification
-
Strategic licensing and co-development agreements
Market Drivers
-
Rising global cancer incidence
-
Demand for targeted and precision medicines
-
Advances in enzyme-inhibition drug design
-
Growing biotech investment and pipeline diversification
Market Challenges
-
Balancing efficacy with long-term safety
-
Limited patient populations in rare indications
-
High clinical and commercialization costs
Value Chain Analysis
-
Target Identification & Validation
-
Drug Discovery & Preclinical Research
-
Clinical Trials (Phase I–III)
-
Regulatory Approval
-
Manufacturing & Quality Assurance
-
Hospital & Specialty Clinic Distribution
Quick Recommendations for Stakeholders
-
Pharmaceutical Companies: Focus on safety-optimized inhibitor platforms and combination regimens
-
Biotech Firms: Pursue niche indications with fast-track and orphan designations
-
Investors: Prioritize companies with late-stage MetAP2 assets and diversified pipelines
-
Healthcare Providers: Prepare for integration of targeted angiogenesis inhibitors
-
Regulators: Support adaptive trial designs for rare and oncology indications
Conclusion
The Methionine Aminopeptidase 2 market represents a high-value, innovation-driven segment within the targeted therapeutics landscape. While clinical complexity and safety considerations remain, continued scientific advances and strategic collaborations are expected to drive steady market expansion through 2036. MetAP2 inhibition is increasingly positioned as a multi-indication therapeutic platform with long-term growth potential.
Table of Contents
Global Methionine Aminopeptidase 2 Market Research Report 2026
1 Industry Overview of Methionine Aminopeptidase 2
1.1 Definition and Specifications of Methionine Aminopeptidase 2
1.1.1 Definition of Methionine Aminopeptidase 2
1.1.2 Specifications of Methionine Aminopeptidase 2
1.2 Classification of Methionine Aminopeptidase 2
1.2.1 APL-1301
1.2.2 M-8891
1.2.3 RSF-101
1.2.4 SDX-7195
1.2.5 Others
1.3 Applications of Methionine Aminopeptidase 2
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Segment by Regions
1.4.1 North America
1.4.2 Europe
1.4.3 China
1.4.4 Japan
1.4.5 Southeast Asia
1.4.6 India
2 Manufacturing Cost Structure Analysis of Methionine Aminopeptidase 2
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Methionine Aminopeptidase 2
2.3 Manufacturing Process Analysis of Methionine Aminopeptidase 2
2.4 Industry Chain Structure of Methionine Aminopeptidase 2
3 Technical Data and Manufacturing Plants Analysis of Methionine Aminopeptidase 2
3.1 Capacity and Commercial Production Date of Global Methionine Aminopeptidase 2 Major Manufacturers
3.2 Manufacturing Plants Distribution of Global Methionine Aminopeptidase 2 Major Manufacturers
3.3 R&D Status and Technology Source of Global Methionine Aminopeptidase 2 Major Manufacturers
3.4 Raw Materials Sources Analysis of Global Methionine Aminopeptidase 2 Major Manufacturers
4 Global Methionine Aminopeptidase 2 Overall Market Overview
4.1 E Overall Market Analysis
4.2 Capacity Analysis
4.2.1 E Global Methionine Aminopeptidase 2 Capacity and Growth Rate Analysis
4.2.2 Methionine Aminopeptidase 2 Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 E Global Methionine Aminopeptidase 2 Sales and Growth Rate Analysis
4.3.2 Methionine Aminopeptidase 2 Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 E Global Methionine Aminopeptidase 2 Sales Price
4.4.2 Methionine Aminopeptidase 2 Sales Price Analysis (Company Segment)
5 Methionine Aminopeptidase 2 Regional Market Analysis
5.1 North America Methionine Aminopeptidase 2 Market Analysis
5.1.1 North America Methionine Aminopeptidase 2 Market Overview
5.1.2 North America E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America E Methionine Aminopeptidase 2 Sales Price Analysis
5.1.4 North America Methionine Aminopeptidase 2 Market Share Analysis
5.2 Europe Methionine Aminopeptidase 2 Market Analysis
5.2.1 Europe Methionine Aminopeptidase 2 Market Overview
5.2.2 Europe E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe E Methionine Aminopeptidase 2 Sales Price Analysis
5.2.4 Europe Methionine Aminopeptidase 2 Market Share Analysis
5.3 China Methionine Aminopeptidase 2 Market Analysis
5.3.1 China Methionine Aminopeptidase 2 Market Overview
5.3.2 China E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.3.3 China E Methionine Aminopeptidase 2 Sales Price Analysis
5.3.4 China Methionine Aminopeptidase 2 Market Share Analysis
5.4 Japan Methionine Aminopeptidase 2 Market Analysis
5.4.1 Japan Methionine Aminopeptidase 2 Market Overview
5.4.2 Japan E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.4.3 Japan E Methionine Aminopeptidase 2 Sales Price Analysis
5.4.4 Japan Methionine Aminopeptidase 2 Market Share Analysis
5.5 Southeast Asia Methionine Aminopeptidase 2 Market Analysis
5.5.1 Southeast Asia Methionine Aminopeptidase 2 Market Overview
5.5.2 Southeast Asia E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia E Methionine Aminopeptidase 2 Sales Price Analysis
5.5.4 Southeast Asia Methionine Aminopeptidase 2 Market Share Analysis
5.6 India Methionine Aminopeptidase 2 Market Analysis
5.6.1 India Methionine Aminopeptidase 2 Market Overview
5.6.2 India E Methionine Aminopeptidase 2 Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India E Methionine Aminopeptidase 2 Sales Price Analysis
5.6.4 India Methionine Aminopeptidase 2 Market Share Analysis
6 Global E Methionine Aminopeptidase 2 Segment Market Analysis (by Type)
6.1 Global E Methionine Aminopeptidase 2 Sales by Type
6.2 Different Types of Methionine Aminopeptidase 2 Product Interview Price Analysis
6.3 Different Types of Methionine Aminopeptidase 2 Product Driving Factors Analysis
6.3.1 APL-1301 Growth Driving Factor Analysis
6.3.2 M-8891 Growth Driving Factor Analysis
6.3.3 RSF-101 Growth Driving Factor Analysis
6.3.4 SDX-7195 Growth Driving Factor Analysis
6.3.5 Others Growth Driving Factor Analysis
7 Global E Methionine Aminopeptidase 2 Segment Market Analysis (by Application)
7.1 Global E Methionine Aminopeptidase 2 Consumption by Application
7.2 Different Application of Methionine Aminopeptidase 2 Product Interview Price Analysis
7.3 Different Application of Methionine Aminopeptidase 2 Product Driving Factors Analysis
7.3.1 Hospital of Methionine Aminopeptidase 2 Growth Driving Factor Analysis
7.3.2 Clinic of Methionine Aminopeptidase 2 Growth Driving Factor Analysis
7.3.3 Others of Methionine Aminopeptidase 2 Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Methionine Aminopeptidase 2
8.1 Asieris Pharmaceuticals Co Ltd
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.2.1 Product A
8.1.2.2 Product B
8.1.3 Asieris Pharmaceuticals Co Ltd Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 Asieris Pharmaceuticals Co Ltd Methionine Aminopeptidase 2 Business Region Distribution Analysis
8.2 Chong Kun Dang Pharmaceutical Corp
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.2.1 Product A
8.2.2.2 Product B
8.2.3 Chong Kun Dang Pharmaceutical Corp Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Chong Kun Dang Pharmaceutical Corp Methionine Aminopeptidase 2 Business Region Distribution Analysis
8.3 Merck KGaA
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.2.1 Product A
8.3.2.2 Product B
8.3.3 Merck KGaA Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Merck KGaA Methionine Aminopeptidase 2 Business Region Distribution Analysis
8.4 SynDevRx Inc
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.2.1 Product A
8.4.2.2 Product B
8.4.3 SynDevRx Inc Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 SynDevRx Inc Methionine Aminopeptidase 2 Business Region Distribution Analysis
8.5 Takeda Pharmaceutical Co Ltd
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.2.1 Product A
8.5.2.2 Product B
8.5.3 Takeda Pharmaceutical Co Ltd Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Takeda Pharmaceutical Co Ltd Methionine Aminopeptidase 2 Business Region Distribution Analysis
8.6 Zafgen Inc
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.2.1 Product A
8.6.2.2 Product B
8.6.3 Zafgen Inc Methionine Aminopeptidase 2 Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Zafgen Inc Methionine Aminopeptidase 2 Business Region Distribution Analysis
9 Development Trend of Analysis of Methionine Aminopeptidase 2 Market
9.1 Global Methionine Aminopeptidase 2 Market Trend Analysis
9.1.1 Global 2018-2025 Methionine Aminopeptidase 2 Market Size (Volume and Value) Forecast
9.1.2 Global 2018-2025 Methionine Aminopeptidase 2 Sales Price Forecast
9.2 Methionine Aminopeptidase 2 Regional Market Trend
9.2.1 North America 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.2.2 Europe 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.2.3 China 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.2.4 Japan 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.2.5 Southeast Asia 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.2.6 India 2018-2025 Methionine Aminopeptidase 2 Consumption Forecast
9.3 Methionine Aminopeptidase 2 Market Trend (Product Type)
9.4 Methionine Aminopeptidase 2 Market Trend (Application)
10 Methionine Aminopeptidase 2 Marketing Type Analysis
10.1 Methionine Aminopeptidase 2 Regional Marketing Type Analysis
10.2 Methionine Aminopeptidase 2 International Trade Type Analysis
10.3 Traders or Distributors with Contact Information of Methionine Aminopeptidase 2 by Region
10.4 Methionine Aminopeptidase 2 Supply Chain Analysis
11 Consumers Analysis of Methionine Aminopeptidase 2
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
12 Conclusion of the Global Methionine Aminopeptidase 2 Market Professional Survey Report
Methodology
Analyst Introduction
Data Source
List of Tables and Figures
Figure Picture of Methionine Aminopeptidase 2
Table Product Specifications of Methionine Aminopeptidase 2
Table Classification of Methionine Aminopeptidase 2
Figure Global Production Market Share of Methionine Aminopeptidase 2 by Type in
Figure APL-1301 Picture
Table Major Manufacturers of APL-1301
Figure M-8891 Picture
Table Major Manufacturers of M-8891
Figure RSF-101 Picture
Table Major Manufacturers of RSF-101
Figure SDX-7195 Picture
Table Major Manufacturers of SDX-7195
Figure Others Picture
Table Major Manufacturers of Others
Table Applications of Methionine Aminopeptidase 2
Figure Global Consumption Volume Market Share of Methionine Aminopeptidase 2 by Application in
Figure Hospital Examples
Table Major Consumers in Hospital
Figure Clinic Examples
Table Major Consumers in Clinic
Figure Others Examples
Table Major Consumers in Others
Figure Market Share of Methionine Aminopeptidase 2 by Regions
Figure North America Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Figure Europe Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Figure China Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Figure Japan Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Figure Southeast Asia Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Figure India Methionine Aminopeptidase 2 Market Size (Million USD) (2013-2025)
Table Methionine Aminopeptidase 2 Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Methionine Aminopeptidase 2 in
Figure Manufacturing Process Analysis of Methionine Aminopeptidase 2
Figure Industry Chain Structure of Methionine Aminopeptidase 2
Table Capacity and Commercial Production Date of Global Methionine Aminopeptidase 2 Major Manufacturers
Table Manufacturing Plants Distribution of Global Methionine Aminopeptidase 2 Major Manufacturers
Table R&D Status and Technology Source of Global Methionine Aminopeptidase 2 Major Manufacturers
Table Raw Materials Sources Analysis of Global Methionine Aminopeptidase 2 Major Manufacturers
Table Global Capacity, Sales , Price, Cost, Sales Revenue (M USD) and Gross Margin of Methionine Aminopeptidase 2 E
Figure Global E Methionine Aminopeptidase 2 Market Size (Volume) and Growth Rate
Figure Global E Methionine Aminopeptidase 2 Market Size (Value) and Growth Rate
Table E Global Methionine Aminopeptidase 2 Capacity and Growth Rate
Table Global Methionine Aminopeptidase 2 Capacity (K Pcs) List (Company Segment)
Table E Global Methionine Aminopeptidase 2 Sales (K Pcs) and Growth Rate
Table Global Methionine Aminopeptidase 2 Sales (K Pcs) List (Company Segment)
Table E Global Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Table Global Methionine Aminopeptidase 2 Sales Price (USD/Pcs) List (Company Segment)
Figure North America Capacity Overview
Table North America Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure North America E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure North America Methionine Aminopeptidase 2 Sales Market Share
Figure Europe Capacity Overview
Table Europe Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure Europe E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure Europe Methionine Aminopeptidase 2 Sales Market Share
Figure China Capacity Overview
Table China Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure China E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure China Methionine Aminopeptidase 2 Sales Market Share
Figure Japan Capacity Overview
Table Japan Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure Japan E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure Japan Methionine Aminopeptidase 2 Sales Market Share
Figure Southeast Asia Capacity Overview
Table Southeast Asia Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure Southeast Asia E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure Southeast Asia Methionine Aminopeptidase 2 Sales Market Share
Figure India Capacity Overview
Table India Supply, Import, Export and Consumption (K Pcs) of Methionine Aminopeptidase 2 E
Figure India E Methionine Aminopeptidase 2 Sales Price (USD/Pcs)
Figure India Methionine Aminopeptidase 2 Sales Market Share
Table Global E Methionine Aminopeptidase 2 Sales (K Pcs) by Type
Table Different Types Methionine Aminopeptidase 2 Product Interview Price
Table Global E Methionine Aminopeptidase 2 Sales (K Pcs) by Application
Table Different Application Methionine Aminopeptidase 2 Product Interview Price
Table Asieris Pharmaceuticals Co Ltd Information List
Table Product Overview
Table Asieris Pharmaceuticals Co Ltd Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Asieris Pharmaceuticals Co Ltd Methionine Aminopeptidase 2 Business Region Distribution
Table Chong Kun Dang Pharmaceutical Corp Information List
Table Product Overview
Table Chong Kun Dang Pharmaceutical Corp Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Chong Kun Dang Pharmaceutical Corp Methionine Aminopeptidase 2 Business Region Distribution
Table Merck KGaA Information List
Table Product Overview
Table Merck KGaA Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Merck KGaA Methionine Aminopeptidase 2 Business Region Distribution
Table SynDevRx Inc Information List
Table Product Overview
Table SynDevRx Inc Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure SynDevRx Inc Methionine Aminopeptidase 2 Business Region Distribution
Table Takeda Pharmaceutical Co Ltd Information List
Table Product Overview
Table Takeda Pharmaceutical Co Ltd Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Takeda Pharmaceutical Co Ltd Methionine Aminopeptidase 2 Business Region Distribution
Table Zafgen Inc Information List
Table Product Overview
Table Zafgen Inc Methionine Aminopeptidase 2 Revenue (Million USD), Sales (K Pcs), Ex-factory Price (USD/Pcs)
Figure Zafgen Inc Methionine Aminopeptidase 2 Business Region Distribution
Figure Global 2018-2025 Methionine Aminopeptidase 2 Market Size (K Pcs) and Growth Rate Forecast
Figure Global 2018-2025 Methionine Aminopeptidase 2 Market Size (Million USD) and Growth Rate Forecast
Figure Global 2018-2025 Methionine Aminopeptidase 2 Sales Price (USD/Pcs) Forecast
Figure North America 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure China 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Europe 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Southeast Asia 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure Japan 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Figure India 2018-2025 Methionine Aminopeptidase 2 Consumption Volume (K Pcs) and Growth Rate Forecast
Table Global Sales Volume (K Pcs) of Methionine Aminopeptidase 2 by Type 2018-2025
Table Global Consumption Volume (K Pcs) of Methionine Aminopeptidase 2 by Application 2018-2025
Table Traders or Distributors with Contact Information of Methionine Aminopeptidase 2 by Region
Segments Analysis
By Product Type
-
APL-1301
-
M-8891
-
RSF-101
-
SDX-7195
-
Others
By Drug Class (Expanded Segmentation)
-
Small-Molecule MetAP2 Inhibitors
-
Covalent MetAP2 Inhibitors
-
Non-covalent Enzyme Modulators
-
Combination Therapies (MetAP2 + Anti-angiogenic Agents)
By Indication (New Segmentation)
-
Oncology (solid tumors, hematologic malignancies)
-
Metabolic Disorders (obesity, diabetes-related complications)
-
Inflammatory & Autoimmune Diseases
-
Rare Vascular & Proliferative Disorders
By Route of Administration (Added)
-
Oral
-
Injectable
-
Parenteral
By Application
-
Hospital
-
Clinic
-
Others
Key Market Players
Core Manufacturers
-
Asieris Pharmaceuticals
-
Chong Kun Dang Pharmaceutical
-
Merck KGaA
-
SynDevRx
-
Takeda Pharmaceutical
-
Zafgen
Additional & Emerging Players (Expanded)
-
Pfizer Inc
-
Novartis AG
-
BeiGene Ltd
-
Bristol-Myers Squibb
-
Jiangsu Hengrui Medicine
